Clinical Trial Update: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma [NA]

View source ↗

Summary

A clinical trial update describes a safety and efficacy study of intracranially implanted Carmustine for recurrent malignant glioma, with the status currently u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligoastrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma

Drugs mentioned

• Carmustine (BiCNU) (carmustine)

Snippet

Sponsor: Shandong Lanjin Pharmaceuticals Co.,Ltd | Conditions: Anaplastic Astrocytoma, Anaplastic Oligodendroglioma | NA | Status: UNKNOWN